BactiQuant AS's earnings per share without non-recurring items for the
six
months ended in Dec. 2025 was kr-0.22.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was kr-0.46.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 10.70% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was -36.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for BactiQuant AS's EPS without NRI or its related term are showing as below:
OCSE:BACTIQ'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -277.4 Med: -126.5 Max: 10.7
Current: 10.7
During the past 8 years, BactiQuant AS's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 10.70% per year. The lowest was -277.40% per year. And the median was -126.50% per year.
OCSE:BACTIQ's 3-Year EPS without NRI Growth Rate is ranked better than 60.77% of 2419
companies
in the Industrial Products industry
Industry Median: 3.5
vs OCSE:BACTIQ: 10.70
BactiQuant AS's EPS (Diluted) for the
six
months ended in Dec. 2025 was kr-0.22.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was kr-0.46.
BactiQuant AS's EPS (Basic) for the
six
months ended in Dec. 2025 was kr-0.22.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was kr-0.46.
BactiQuant AS (OCSE:BACTIQ) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
BactiQuant AS EPS without NRI Related Terms
BactiQuant AS EPS without NRI Historical Data
* Premium members only.
The historical data trend for BactiQuant AS's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:BACTIQ vs VLTO, ZWS, CECO: EPS without NRI Comparison
For the Pollution & Treatment Controls subindustry, BactiQuant AS's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BactiQuant AS PE Ratio without NRI vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, BactiQuant AS's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where BactiQuant AS's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-0.46
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BactiQuant AS (OCSE:BACTIQ) has a EPS without NRI of kr-0.46 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on BactiQuant AS and its competitors. According to the industry distribution chart, BactiQuant AS ranks #949 out of 2419 companies in the Industrial Products industry, placing it in the top 39.2%.
Is BactiQuant AS's EPS without NRI too high?
BactiQuant AS's current EPS without NRI is kr-0.46. Based on the distribution chart, BactiQuant AS ranks #949 out of 2419 companies in the Industrial Products industry, which is above the industry midpoint. Overall, BactiQuant AS has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BactiQuant AS's EPS without NRI compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, BactiQuant AS ranks #949 out of 2419 companies for EPS without NRI. This puts BactiQuant AS in the upper half of its industry. The industry median EPS without NRI is 3.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for an Industrial Products company?
The median EPS without NRI among Industrial Products companies is 3.50, based on 2,419 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on BactiQuant AS and its competitors. For the Industrial Products industry, the median EPS without NRI is 3.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BactiQuant AS's current EPS without NRI is kr-0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BactiQuant AS stock overvalued right now?
Based on GuruFocus' analysis, BactiQuant AS (OCSE:BACTIQ) is currently considered Fairly Valued. The stock's GF Value™ is kr2.35, compared to a current price of kr2.55 — trading 8.5% above its estimated fair value. The current EPS without NRI is kr-0.46. BactiQuant AS's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For BactiQuant AS (OCSE:BACTIQ), the current EPS without NRI is kr-0.46 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BactiQuant AS (OCSE:BACTIQ) Overvalued in 2026?
Based on GuruFocus' analysis, BactiQuant AS stock appears to be overvalued.
The current stock price of kr2.55 is trading 8.5% above its estimated GF Value™ of kr2.35.
GuruFocus considers BactiQuant AS to be Fairly Valued.
Key valuation signals for OCSE:BACTIQ:
EPS without NRI: kr-0.46
GF Value™: kr2.35 vs. price of kr2.55 (8.5% above fair value)
No single metric tells the full story. See the OCSE:BACTIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BactiQuant AS focuses on delivering technology that ensures optimum usage and handling of water around the world. The company's activities include the development, production, sale and service of BactiQuant Online and BactiQuant Mobile Lab with associated test kits/substrate for the quantification and detection of bacteria in water. Its segments are Aquaculture, Data Centres, Oil & Gas, Water Utility, Industry, and Pharma. The group's products are BQ Online 2.0 PRO, BQ Online, BQ Mobile Lab, and Analysis Kits.
56GF Score
Get the complete analysis for OCSE:BACTIQ
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:BACTIQ has been successfully added to your 
